Signature Resources Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Signature Resources Capital Management, LLC
- $116 Billion
- Q1 2025
A detailed history of Signature Resources Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 14 shares of RARE stock, worth $480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 15
6.67%
Holding current value
$480
Previous $631,000
19.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$343 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$192 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$143 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$111 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$89.9 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.41B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...